Navigation Links
HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sam's Club in Richmond Hill, Ontario
Date:12/10/2007

TORONTO, Dec. 10 /PRNewswire-FirstCall/ -- (Pink Sheets: HRAL) -- HearAtLast Holdings, Inc. is proud to announce that it has received its 16th license from Wal-Mart Canada (NYSE: WMT) to open its 16th hearing-aid clinic to be co-located within the Sam's Club located at 255 Silver Linden Dr. in Richmond Hill, Ontario. The new clinic officially opened over the weekend on Saturday, December 8, 2007. This expansion is a direct result of the Company exercising its option under a master licensing agreement with Wal-Mart Canada Corp. which allows HearAtLast to open hearing aid clinics within numerous Wal- Mart and Sam's locations throughout Canada.

HearAtLast will utilize a specially designed, prefabricated, 220 square foot portable structure designed especially for Sam's Club locations. The modular design of this clinic will provide portability as it can be broken down and reassembled in various locations throughout the store as needed.

While the company will continue co-location programs within the traditional Wal-Mart Stores as well as the Wal-Mart Super Centers, the new portable, prefabricated clinic model designed for Sam's, will allow HearAtLast to expand to new locations with relative ease. Management feels the dual model roll-out will afford the company flexibility as well as being a vital component to drive revenue growth.

"It is an exciting time for us as we continue to add new locations throughout Canada." said Robert Oswald, President of HearAtLast. "We couldn't be more pleased with our roll-out in Canada thus far and we look forward to the opening of our first U.S. location in The Villages, Florida, this coming January of 2008." added Oswald.

The addition of the Richmond Hills Sam's lo
'/>"/>

SOURCE HearAtLast Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Harbinger Research Initiates Coverage on HearAtLast
2. HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053
3. HearAtLast Teams Up with American Express and Wal-Mart to Conquer Hearing Loss
4. HearAtLast Announces Completion of Initial Private Placement Financing Totaling US $1,000,000
5. HearAtLast Spokesperson Walter Gretzky and President Robert Oswald to be Featured on Three TV Segments in Conjunction with Ottawa Store Opening
6. Battle Continues Over Vietnam PTSD Numbers
7. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
8. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
9. Securians Minnesota Life Continues to Climb Group Life Rankings
10. USA TODAY Continues Spirit of the USA Charity Program as Part of Newspapers 25th Anniversary Celebration
11. United States continues to have highest level of health spending
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... Brain perfusion application is...e using the Ziostation® thin-client system. ,...B) January 8, 2009 -- Ziosoft®, Inc. , a lead... for medical imaging , today announced that it ha... Drug Administration (FDA) for its CT brain perfus...
(Date:1/7/2009)...ATTLE, Jan. 8 Cell Thera...ed today that they received $7.5 million pursuant ...rmaceuticals, Inc. to commercialize and develop Ze...mpany received the initial $7.5 million payment in... The Company may earn up to an additional $15 mill...
(Date:1/7/2009)...TON The drive toward containing health care costs... physician productivity, impairing quality and per...ess Medical Center physicians suggest in a New En...g studies in behavioral economics and psychology, ...ss the fear that assigning a monetary value to eve...
(Date:1/7/2009)...ARCOS, Calif., Jan, 7 Natural Alternatives Intern... formulator, manufacturer and marketer of customiz...ffective December 31, 2008 its former President, R...I also announced it completed certain amendments t...g other changes the amendments extend the maturity...
Breaking Medicine News(10 mins):Health News:Ziosoft Receives FDA Clearance for CT Brain Perfusion Application 2Health News:Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals 2Health News:Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals 3Health News:Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals 4Health News:Cost containment focus could have consequences for health care delivery 2Health News:Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension 2
...to the conference held at Varca in Goa it is found...rom high homocysteine levels. //The two day confe...und that extreme vegetarian practices lead to hype...ituation by increasing the risk of developing dise...
...onship between obesity in childhood and extent of ...ording to a recent study based on Scottish childre...derlying connection between the extent of physical...e finding hovered around the importance of genetic...
...Kashmir health department today advised people to ...ood of increase in water-borne diseases like diarr...ve been asked to boil drinking water for at least ...getables and fruit thoroughly before eating, an of...
...udies published in the Mayo Clinic Proceedings rev...awal and cocaine use with the onset of cardiac syn...cterized by chest pain, shortness of breath mimics...hed light on ‘broken heart syndrome,’ a still some...
Other Medicine News:Health News:Sudden Opioid Withdrawal Results in ‘Broken Heart Syndrome 2
(Date:1/7/2009)...wswire-USNewswire/ -- Scientists have identified m...of relapse in children with acute lymphoblastic le...t further research is needed to determine how chan...to leukemia relapse, the findings are likely to pr...ess the risk of treatment failure. By using a mole...
(Date:1/7/2009)... 7 Circassia Ltd, a specialty,bio...ical care, today,announced that following success...leroMune(R) anti-allergy technology, the company h...r phase II clinical trial in cat allergy. The,stu... patients with confirmed,cat allergies, and all t...
(Date:1/6/2009)...wswire-USNewswire/ -- Sequella, Inc., a clinical-s... of epidemic potential, announced today that SQ109...erculosis (TB), was the first drug approved for ev...act to Dynport Vaccine Company LLC and Quintiles T...l Institute of Allergy and Infectious Diseases (NI...
(Date:1/5/2009)...RNewswire-FirstCall/ -- Micromet, Inc.,(Nasdaq: ...vel, proprietary,antibodies for the treatment of ...vides an outlook on key events anticipated for the... an update on its research and development,progra...o 16, 2009: Update on several preclinical BiTE ant...
Breaking Medicine Technology:Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5Dialysis Corporation of America Announces Fiscal Year 2007 Earnings Release Date 13139 1Dialysis Corporation of America Announces Fiscal Year 2007 Earnings Release Date 13139 2ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old 13137 1ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old 13137 2ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old 13137 3ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old 13137 4Large source of nitrate a potential water contaminant found in near surface desert soils 13135 1Large source of nitrate a potential water contaminant found in near surface desert soils 13135 2Large source of nitrate a potential water contaminant found in near surface desert soils 13135 3Springer to publish International Journal of Hematology 13133 1Springer to publish International Journal of Hematology 13133 2
...HLIEREN (Zurich), Switzerland, March 13, 2007 -,Cy...itive results,from a phase IIa study with CYT003-Q...he treatment of allergic diseases. The study,inclu...lergic,rhinitis due to grass pollen allergy (hay f...ting the safety, tolerability and,exploratory effi...
...DNEY, Australia, March 14, 2007 /Xinhua-PRNewswire...day announced the results,from its Phase II trial ...lmonary Disease (COPD), a respiratory disease,affe...l was conducted in 79 diagnosed COPD patients at 1...he trial was to,determine if subjects that were po...
Other Medicine Technology:Placebo-controlled Phase IIa Study with the Immunotherapeutic,CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in,Hay Fever Patients 2Placebo-controlled Phase IIa Study with the Immunotherapeutic,CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in,Hay Fever Patients 3Placebo-controlled Phase IIa Study with the Immunotherapeutic,CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in,Hay Fever Patients 4Placebo-controlled Phase IIa Study with the Immunotherapeutic,CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in,Hay Fever Patients 5Placebo-controlled Phase IIa Study with the Immunotherapeutic,CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in,Hay Fever Patients 6Placebo-controlled Phase IIa Study with the Immunotherapeutic,CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in,Hay Fever Patients 7Pharmaxis Reports Phase II Results for Aridol in COPD 2Pharmaxis Reports Phase II Results for Aridol in COPD 3Pharmaxis Reports Phase II Results for Aridol in COPD 4
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: